Ascendis Pharma A/S (ASND)
Ascendis Pharma Market Cap : 14.14B for March 16, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Novo Nordisk A/S | 169.10B |
| Evaxion AS | 33.03M |
| DBV Technologies SA | 1.117B |
| Biodexa Pharmaceuticals Plc | 0.6626M |
| Mereo BioPharma Group Plc | 61.93M |
Market Cap Related Metrics
| PS Ratio | 16.97 |
| Price to Free Cash Flow | 271.57 |
| Price | 230.35 |
| Earnings Yield | -1.82% |